Aithal GP - Search Results

1

Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study.

Grove JI, Stephens C, Lucena MI, Andrade RJ, Weber S, Gerbes A, Bjornsson ES, Stirnimann G, Daly AK, Hackl M, Khamina-Kotisch K, Marin JJG, Monte MJ, Paciga SA, Lingaya M, Forootan SS, Goldring CEP, Poetz O, Lombaard R, Stege A, Bjorrnsson HK, Robles-Diaz M, Li D, Tran TDB, Ramaiah SK, Samodelov SL, Kullak-Ublick GA, Aithal GP; TransBioLine consortium. Grove JI, et al. Among authors: aithal gp. Diagn Progn Res. 2023 Sep 12;7(1):18. doi: 10.1186/s41512-023-00155-z. Diagn Progn Res. 2023. PMID: 37697410 Free PMC article.

2

CYP2C9 polymorphism and warfarin dose requirements.

Daly AK, Day CP, Aithal GP. Daly AK, et al. Among authors: aithal gp. Br J Clin Pharmacol. 2002 Apr;53(4):408-9. doi: 10.1046/j.1365-2125.2002.01572_6.x. Br J Clin Pharmacol. 2002. PMID: 11966680 Free PMC article. No abstract available.

3

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.

Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J, Day CP. Aithal GP, et al. Hepatology. 2004 May;39(5):1430-40. doi: 10.1002/hep.20205. Hepatology. 2004. PMID: 15122773

4

Genetic regulation of warfarin metabolism and response.

Daly AK, Aithal GP. Daly AK, et al. Among authors: aithal gp. Semin Vasc Med. 2003 Aug;3(3):231-8. doi: 10.1055/s-2003-44458. Semin Vasc Med. 2003. PMID: 15199455 Review.

5

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

King BP, Khan TI, Aithal GP, Kamali F, Daly AK. King BP, et al. Among authors: aithal gp. Pharmacogenetics. 2004 Dec;14(12):813-22. doi: 10.1097/00008571-200412000-00004. Pharmacogenetics. 2004. PMID: 15608560

6

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

Daly AK, Aithal GP, Leathart JB, Swainsbury RA, Dang TS, Day CP. Daly AK, et al. Among authors: aithal gp. Gastroenterology. 2007 Jan;132(1):272-81. doi: 10.1053/j.gastro.2006.11.023. Epub 2006 Nov 17. Gastroenterology. 2007. PMID: 17241877

7

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP; DILIGEN Study; International SAE Consortium. Daly AK, et al. Among authors: aithal gp. Nat Genet. 2009 Jul;41(7):816-9. doi: 10.1038/ng.379. Epub 2009 May 31. Nat Genet. 2009. PMID: 19483685

8

A role for the pregnane X receptor in flucloxacillin-induced liver injury.

Andrews E, Armstrong M, Tugwood J, Swan D, Glaves P, Pirmohamed M, Aithal GP, Wright MC, Day CP, Daly AK. Andrews E, et al. Among authors: aithal gp. Hepatology. 2010 May;51(5):1656-64. doi: 10.1002/hep.23549. Hepatology. 2010. PMID: 20222094

9

Preempting and preventing drug-induced liver injury.

Aithal GP, Daly AK. Aithal GP, et al. Nat Genet. 2010 Aug;42(8):650-1. doi: 10.1038/ng0810-650. Nat Genet. 2010. PMID: 20664647 No abstract available.

10

Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.

Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, Day CP, Aithal GP. Donaldson PT, et al. Among authors: aithal gp. J Hepatol. 2010 Dec;53(6):1049-53. doi: 10.1016/j.jhep.2010.05.033. Epub 2010 Aug 1. J Hepatol. 2010. PMID: 20800921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page